Navelbine and thrombocytopenia Patient Reports February 11, 2012

Navelbine Side Effects Report #4692729-5
Navelbine side effect was reported by a Health Professional from on June 07, 2005. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: haematemesis, neutropenia, pyrexia, thrombocytopenia. Navelbine dosage: 30MG PER DAY. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 06/01/2005.

Navelbine Side Effects Report #4710834-1
Navelbine side effect was reported by a Health Professional from JAPAN on June 07, 2005. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, haemoptysis, leukopenia, malaise, pyrexia, respiratory arrest, thrombocytopenia. Navelbine dosage: 30MG PER DAY. During the same period patient was treated with PARAPLATIN, KLARICID, MUCOSOLVAN, PREDONINE, GASTER, METHYLCOBAL, HEAVY MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 06/01/2005.

Navelbine Side Effects Report #5955518-7
Navelbine side effect was reported by a Consumer or non-health professional from ITALY on Nov 04, 2008. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: asthenia, dyspepsia, neutropenia, thrombocytopenia. Navelbine dosage: unknown. During the same period patient was treated with CISPLATIN, PLASIL, FLUTICASONE PROPIONATE. Patient recovered.

Navelbine Side Effects Report #5713862-2
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Apr 08, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, thrombocytopenia. Navelbine dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient recovered.


Navelbine Side Effects Report #5732551-1
Navelbine side effect was reported by a Health Professional from JAPAN on Apr 23, 2008. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, metastases to liver, thrombocytopenia. Navelbine dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5421622-5
Navelbine side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Sept 27, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: thrombocytopenia. Navelbine dosage: 25 MG/M2 IV. During the same period patient was treated with GEMCITABINE, CHLORIDE, DOLASETRON, DEXAMETHASONE, LORAZEPAM. Patient recovered.

Navelbine Side Effects Report #5421623-7
Navelbine side effect was reported by a Consumer or non-health professional from GREECE on Aug 17, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: thrombocytopenia. Navelbine dosage: 25 MG/M2 IV. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, ONDANSETRON. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4907155-0
Navelbine side effect was reported by a Health Professional from JAPAN on Aug 19, 2005. Male patient, 65 years of age, was diagnosed with lung neoplasm malignant and was treated with Navelbine. After drug was administered, patient experienced the following side effects: cholangitis, hepatic function abnormal, pyrexia, thrombocytopenia. Navelbine dosage: unknown. During the same period patient was treated with GEMZAR. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4907143-4
Navelbine side effect was reported by a Health Professional from FRANCE on Dec 20, 2005. Male patient, 58 years of age, was diagnosed with lung adenocarcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: neutropenia, pulmonary embolism , septic shock, thrombocytopenia. Navelbine dosage: unknown. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #5906775-4
Navelbine side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 18, 2008. Male patient was diagnosed with burkitt's lymphoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: bone marrow failure, neutropenia, pneumonia , pneumonia bacterial, stenotrophomonas infection, thrombocytopenia. Navelbine dosage: 20 MG/M2 IV. During the same period patient was treated with GEMCITABINE, TOPOTECAN, THIOTEPA, DEXAMETHASONE, NEUPOGEN. Patient died.

Navelbine Side Effects Report #5632997-6
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Jan 25, 2008. Female patient, 67 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haematocrit decreased, leukopenia, metastases to bone, red blood cell count decreased, renal failure acute, thrombocytopenia. Navelbine dosage: 0 MG/M2 QD IV. Patient died on 12/29/2007.

Navelbine Side Effects Report #5647196-1
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Jan 25, 2008. Female patient, 67 years of age, was diagnosed with breast cancer recurrent and was treated with Navelbine. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, leukopenia, metastases to bone, renal failure acute, thrombocytopenia. Navelbine dosage: 0 MG/M2 QD IV. Patient died on 12/29/2007.

Navelbine Side Effects Report #5528997-7
Navelbine side effect was reported by a Consumer or non-health professional from ITALY on Oct 29, 2007. Female patient, 76 years of age, was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anaemia, disease progression, haematotoxicity, thrombocytopenia, transient ischaemic attack. Navelbine dosage: 50 MG/M2 IV. During the same period patient was treated with GEMCITABINE. Patient recovered.

Navelbine Side Effects Report #5025966-0
Navelbine side effect was reported by a Consumer or non-health professional from GERMANY on May 02, 2006. Female patient, 73 years of age, was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: dizziness , gingival bleeding, haematoma, petechiae, subdural haematoma, thrombocytopenia. Navelbine dosage: 45 MG EVERY DAY INTRAVENOUS. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #5722896-3
Navelbine side effect was reported by a Consumer or non-health professional from JAPAN on Apr 11, 2008. Female patient, 58 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: haematuria, haemorrhage, thrombocytopenia. Navelbine dosage: 25 MG/M2 QD IV. During the same period patient was treated with HERCEPTIN, AMLODIN, OLMETEC, DEPAKENE, FAMOTIDINE, RINDERON, LOXOPROFEN, MUCOSTA. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5500361-6
Navelbine side effect was reported by a Consumer or non-health professional from FRANCE on Aug 01, 2007. Male patient, 50 years of age, was treated with Navelbine. After drug was administered, patient experienced the following side effects: mucosal inflammation, status epilepticus, thrombocytopenia. Navelbine dosage: 40 MG IV. During the same period patient was treated with HOLOXAN, NOVANTRONE, ACUPAN, CLAFORAN, BACTRIM, VANCOMYCIN, TRIFLUCAN. Patient was hospitalized. Patient recovered.